查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041836

2034年體外心律調節器市場預測：按設備、應用、最終用戶和地區分類的全球分析

External Pacemaker Market Forecasts to 2034 - Global Analysis By Device (Single Chamber and Dual Chamber), By Application (Acute Myocardial Infarction, Bradycardia, Heart Block and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球體外心律調節器市場規模將達到 19 億美元，並在預測期內以 5.4% 的複合年成長率成長，到 2034 年將達到 29 億美元。

體外心律調節器是醫療設備，旨在透過外部電源發送電脈衝來調節心率。它由連接到外部發生器的電極組成，該發生器發出可控的電訊號。該裝置佩戴在患者胸部，向心臟輸送電脈衝，以糾正心搏過緩等心律不整和其他傳導異常，直到找到永久性治療方法。

根據美國疾病管制與預防中心（CDC）的數據，大約每40秒就有一名美國人心臟病發作。每年，有80.5萬美國人心臟病發作，其中60.5萬人是首次心臟病發作。

人口老化的進程

老年人常出現心律不整，例如心搏過緩緩和心臟傳導阻滯。隨著人口老化，需要植入心臟節律器的心臟病患者數量不斷增加。在這些情況下，體外心律調節器可作為一種臨時解決方案，在患者等待永久性植入手術期間提供即時的心臟支持，或作為心血管手術後的臨時措施。此外，全球人口老化與體外心律調節器需求的成長直接相關，推動了市場成長。

心臟心律調節器高成本

這些設備對心臟疾病的治療至關重要，但購買和維護成本高。先進的技術、材料和製造流程是造成其價格高昂的主要原因。此外，某些地區的醫療預算限制和保險覆蓋範圍有限，也造成了經濟障礙，阻礙了患者使用這些救命設備，從而限制了它們的廣泛應用。

新興國家可支配所得增加

新興經濟體居民收入水準的提高使他們能夠負擔得起包括心臟心律調節器在內的先進醫療服務和設備。這增加了對心臟護理的需求，並提高了獲得昂貴醫療技術的途徑。經濟負擔的減輕使得更多人能夠選擇心臟心律調節器植入手術和治療，推動了市場成長。此外，醫療保健成本的上升和保險覆蓋範圍的擴大也促進了心律調節器普及率的提高，為這些國家創造了有利的市場環境。

與替代療法的競爭

藥物治療、生活方式調整和其他非侵入性心臟治療等替代療法，是心律調節器植入術的替代方案。在某些心臟疾病中，患者可能由於擔心手術、設備依賴性或費用問題，在考慮心律調節器之前先選擇替代療法。此外，非侵入性手術的進步和替代療法的研究，可能會提供更多切實可行的選擇，並降低患者即時植入心律調節器的需求。

新冠疫情的影響：

新冠疫情對體外心律調節器市場產生了重大影響。醫療服務、擇期手術和門診就診的中斷導致非緊急治療（包括心律調節器植入）被推遲。供應鏈中斷以及疫情相關醫療資源的優先分配影響了心律調節器的供應。患者就醫或住院的猶豫也導致心律調節器手術數量下降，造成市場成長暫時放緩。

在預測期內，醫院板塊預計將成為最大的板塊。

在預測期內，醫院預計將成為市場的主要驅動力。醫院是心臟護理的主要中心，擁有專業的設施和技術精湛的醫護人員，能夠診斷和治療需要體外心律調節器的複雜心臟疾病。此外，這些機構通常會接收大量需要緊急心臟介入的患者，使其成為心律調節器植入和管理的主要中心。醫院提供的全面醫療服務和專業的循環系統科室鞏固了其作為體外心律調節器市場最大貢獻者的地位。

在預測期內，心臟傳導阻滯細分市場預計將呈現最高的複合年成長率。

在預測期內，心臟傳導阻滯市場預計將呈現高速成長。這主要是由於心臟傳導阻滯症的盛行率不斷上升，這類疾病會導致心臟電訊號延遲或阻斷。在這種情況下，體外心律調節器成為調節心律的重要臨時解決方案，推動了市場對其需求的成長。此外，技術的進步和心血管健康意識的提高預計將加速體外心律調節器在心臟傳導阻滯治療中的應用，進一步促進該市場的快速成長。

市佔率最大的地區：

由於北美擁有先進的醫療基礎設施、心臟病高發生率和高額醫療費用支出，預計將在體外心律調節器市場佔據最大的市場佔有率。此外，主要市場參與者的存在以及廣泛的研發活動也鞏固了其市場主導地位。同時，北美在心臟護理技術進步方面不斷加大投入，並積極採用創新醫療解決方案，進一步鞏固了其在體外心律調節器市場的領先地位。

複合年成長率最高的地區：

由於心臟病患病率上升和人口老化，亞太地區的體外心律調節器市場預計將顯著成長。此外，醫療基礎設施的改善、人們對先進醫療技術的認知度提高以及可支配收入的增加，都促進了體外心律調節器普及率的提升。同時，與國際醫療設備製造商的合作以及政府的支持措施也進一步推動了市場擴張，為亞太地區的體外心律調節器市場帶來了巨大的成長前景。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球體外心律調節器市場：依設備類型分類

  • 單人房
  • 雙腔體

第6章 全球體外心律調節器市場：依應用分類

  • 急性心肌梗塞
  • 心搏過緩
  • 心臟傳導阻滯
  • 術後護理
  • 心搏過速
  • 其他用途

第7章 全球體外心律調節器市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 診所
  • 家庭醫療保健
  • 其他最終用戶

第8章 全球體外心律調節器市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • Cook Medical
  • Galix Biomedical Instrumentation
  • LivaNova Plc
  • Medtronic
  • Osypka Medical GmbH
  • Reka Health Pte Ltd.
  • Schiller AG
  • Shree Pacetronix Ltd.
  • Spacelabs Healthcare
  • ZOLL Medical Corporation
Product Code: SMRC24902

According to Stratistics MRC, the Global External Pacemaker Market is accounted for $1.9 billion in 2026 and is expected to reach $2.9 billion by 2034 growing at a CAGR of 5.4% during the forecast period. An external pacemaker is a medical device designed to regulate heart rhythm by delivering electrical impulses externally. It consists of electrodes connected to an external generator that emits controlled electrical signals. This device is placed on the patient's chest and transmits electrical pulses to the heart, addressing abnormal heart rhythms like bradycardia or other conduction abnormalities until a permanent solution is implemented.

According to the Centers for Disease Control and Prevention (CDC), approximately every 40 seconds an American will have a heart attack. Every year, 805,000 Americans have a heart attack, 605,000 of them for the first time.

Market Dynamics:

Driver:

Growing geriatric population

Elderly individuals commonly experience heart rhythm abnormalities like bradycardia or heart block. As the ageing demographic expands, there's a higher prevalence of cardiac conditions necessitating pacemaker intervention. External pacemakers serve as temporary solutions in these cases, providing immediate cardiac support while patients await permanent implantation or temporary measure post-cardiac procedures. Additionally, the rising ageing population worldwide directly correlates with an increased demand for external pacemakers, fostering market growth.

Restraint:

High cost of pacemakers

These devices are crucial for cardiac management, but they involve substantial expenses for both procurement and maintenance. The sophisticated technology, materials, and manufacturing processes contribute to elevated prices. Additionally, healthcare budget constraints and limited insurance coverage in certain regions create financial barriers, hindering patient access to these life-saving devices, which limits their accessibility to a broader population.

Opportunity:

Increasing disposable income in emerging economies

Due to the rise in income levels, emerging economies can afford advanced healthcare services and devices, including pacemakers. This leads to a higher demand for cardiac care and better access to expensive medical technologies. Improved affordability allows a larger segment of the population to opt for pacemaker implantations or treatments, boosting market growth. Moreover, increased healthcare spending and better insurance coverage contribute to expanded adoption rates, creating a favourable market landscape in these economies.

Threat:

Competition from alternative therapies

Alternative treatments like medication, lifestyle changes, or other non-invasive cardiac interventions present alternatives to pacemaker implantation. For certain cardiac conditions, patients might opt for alternative therapies before considering a pacemaker due to concerns about surgery, device dependency, or cost. Moreover, advancements in non-invasive procedures and research into alternative treatments offer viable options, potentially reducing the immediate need for pacemakers.

Covid-19 Impact:

The COVID-19 pandemic had a substantial impact on the external pacemaker market. Disruptions in healthcare services, elective procedures, and hospital visits led to deferred non-emergency treatments, including pacemaker implantations. Supply chain disruptions and the prioritisation of resources for pandemic-related care affected device availability. Patient reluctance to seek medical care and hospitalisations also contributed to reduced pacemaker procedures, resulting in a temporary decline in market growth.

The hospitals segment is expected to be the largest during the forecast period

During the forecast period, the hospitals segment is poised to dominate. Hospitals serve as primary centres for cardiac care, equipped with specialised infrastructure and skilled healthcare professionals capable of diagnosing and treating complex cardiac conditions requiring external pacemakers. Additionally, these facilities often witness a high influx of patients requiring immediate cardiac interventions, making them primary hubs for pacemaker implantations and management. The comprehensive healthcare services and specialised cardiology departments in hospitals solidify their position as the largest contributors to the external pacemaker market.

The heart block segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the heart block segment is anticipated to experience a lucrative growth rate. This is attributed to the increasing prevalence of heart block conditions, where the heart's electrical signals are delayed or obstructed. External pacemakers serve as essential temporary solutions for regulating the heart's rhythm in such cases, contributing to their heightened demand. Additionally, advancements in technology and a growing awareness of cardiac health are expected to drive the adoption of external pacemakers for heart block management, fueling the segment's rapid growth.

Region with largest share:

North America is positioned to secure the largest market share in the external pacemaker market owing to its advanced healthcare infrastructure, high prevalence of cardiac disorders, and substantial healthcare expenditure. Additionally, the presence of key market players and extensive research and development activities contribute to market dominance. Furthermore, increasing initiatives for technological advancements in cardiac care and a proactive approach to adopting innovative medical solutions reinforce North America's prominence in the external pacemaker market.

Region with highest CAGR:

The Asia-Pacific region is poised for significant growth in the external pacemaker market due to the region's rising prevalence of cardiac disorders and an expanding geriatric population. Additionally, improving healthcare infrastructure, growing awareness about advanced medical treatments, and rising disposable incomes contribute to higher adoption rates of external pacemakers. Moreover, collaborations with international medical device manufacturers and supportive government initiatives further drive market expansion, indicating substantial growth prospects for the Asia-Pacific External Pacemaker market.

Key players in the market

Some of the key players in External Pacemaker Market include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Cardiac Science Corporation, Cook Medical, Galix Biomedical Instrumentation, LivaNova Plc, Medtronic, Osypka Medical GmbH, Reka Health Pte Ltd., Schiller AG, Shree Pacetronix Ltd., Spacelabs Healthcare and ZOLL Medical Corporation.

Key Developments:

In December 2023, Medtronic plc, a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven partnership will further capitalize on the achievements already realized with the GI Genius(TM) intelligent endoscopy module, offering continued innovation and scalable healthcare advancements for patients and caregivers globally.

In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept(R) Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain. The Intracept system, a basivertebral nerve ablation therapy, will be an addition to the Boston Scientific chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure.

In July 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR(TM) dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.

Devices Covered:

  • Single Chamber
  • Dual Chamber

Applications Covered:

  • Acute Myocardial Infarction
  • Bradycardia
  • Heart Block
  • Post-Operative Care
  • Tachycardia
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Home Healthcare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global External Pacemaker Market, By Device

  • 5.1 Introduction
  • 5.2 Single Chamber
  • 5.3 Dual Chamber

6 Global External Pacemaker Market, By Application

  • 6.1 Introduction
  • 6.2 Acute Myocardial Infarction
  • 6.3 Bradycardia
  • 6.4 Heart Block
  • 6.5 Post-Operative Care
  • 6.6 Tachycardia
  • 6.7 Other Applications

7 Global External Pacemaker Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Clinics
  • 7.5 Home Healthcare
  • 7.6 Other End Users

8 Global External Pacemaker Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Biotronik
  • 10.3 Boston Scientific Corporation
  • 10.4 Cardiac Science Corporation
  • 10.5 Cook Medical
  • 10.6 Galix Biomedical Instrumentation
  • 10.7 LivaNova Plc
  • 10.8 Medtronic
  • 10.9 Osypka Medical GmbH
  • 10.10 Reka Health Pte Ltd.
  • 10.11 Schiller AG
  • 10.12 Shree Pacetronix Ltd.
  • 10.13 Spacelabs Healthcare
  • 10.14 ZOLL Medical Corporation

List of Tables

  • Table 1 Global External Pacemaker Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global External Pacemaker Market Outlook, By Device (2023-2034) ($MN)
  • Table 3 Global External Pacemaker Market Outlook, By Single Chamber (2023-2034) ($MN)
  • Table 4 Global External Pacemaker Market Outlook, By Dual Chamber (2023-2034) ($MN)
  • Table 5 Global External Pacemaker Market Outlook, By Application (2023-2034) ($MN)
  • Table 6 Global External Pacemaker Market Outlook, By Acute Myocardial Infarction (2023-2034) ($MN)
  • Table 7 Global External Pacemaker Market Outlook, By Bradycardia (2023-2034) ($MN)
  • Table 8 Global External Pacemaker Market Outlook, By Heart Block (2023-2034) ($MN)
  • Table 9 Global External Pacemaker Market Outlook, By Post-Operative Care (2023-2034) ($MN)
  • Table 10 Global External Pacemaker Market Outlook, By Tachycardia (2023-2034) ($MN)
  • Table 11 Global External Pacemaker Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 12 Global External Pacemaker Market Outlook, By End User (2023-2034) ($MN)
  • Table 13 Global External Pacemaker Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 14 Global External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 15 Global External Pacemaker Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 16 Global External Pacemaker Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 17 Global External Pacemaker Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 18 North America External Pacemaker Market Outlook, By Country (2023-2034) ($MN)
  • Table 19 North America External Pacemaker Market Outlook, By Device (2023-2034) ($MN)
  • Table 20 North America External Pacemaker Market Outlook, By Single Chamber (2023-2034) ($MN)
  • Table 21 North America External Pacemaker Market Outlook, By Dual Chamber (2023-2034) ($MN)
  • Table 22 North America External Pacemaker Market Outlook, By Application (2023-2034) ($MN)
  • Table 23 North America External Pacemaker Market Outlook, By Acute Myocardial Infarction (2023-2034) ($MN)
  • Table 24 North America External Pacemaker Market Outlook, By Bradycardia (2023-2034) ($MN)
  • Table 25 North America External Pacemaker Market Outlook, By Heart Block (2023-2034) ($MN)
  • Table 26 North America External Pacemaker Market Outlook, By Post-Operative Care (2023-2034) ($MN)
  • Table 27 North America External Pacemaker Market Outlook, By Tachycardia (2023-2034) ($MN)
  • Table 28 North America External Pacemaker Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 29 North America External Pacemaker Market Outlook, By End User (2023-2034) ($MN)
  • Table 30 North America External Pacemaker Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 31 North America External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 32 North America External Pacemaker Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 33 North America External Pacemaker Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 34 North America External Pacemaker Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 35 Europe External Pacemaker Market Outlook, By Country (2023-2034) ($MN)
  • Table 36 Europe External Pacemaker Market Outlook, By Device (2023-2034) ($MN)
  • Table 37 Europe External Pacemaker Market Outlook, By Single Chamber (2023-2034) ($MN)
  • Table 38 Europe External Pacemaker Market Outlook, By Dual Chamber (2023-2034) ($MN)
  • Table 39 Europe External Pacemaker Market Outlook, By Application (2023-2034) ($MN)
  • Table 40 Europe External Pacemaker Market Outlook, By Acute Myocardial Infarction (2023-2034) ($MN)
  • Table 41 Europe External Pacemaker Market Outlook, By Bradycardia (2023-2034) ($MN)
  • Table 42 Europe External Pacemaker Market Outlook, By Heart Block (2023-2034) ($MN)
  • Table 43 Europe External Pacemaker Market Outlook, By Post-Operative Care (2023-2034) ($MN)
  • Table 44 Europe External Pacemaker Market Outlook, By Tachycardia (2023-2034) ($MN)
  • Table 45 Europe External Pacemaker Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 46 Europe External Pacemaker Market Outlook, By End User (2023-2034) ($MN)
  • Table 47 Europe External Pacemaker Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 48 Europe External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 49 Europe External Pacemaker Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 50 Europe External Pacemaker Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 51 Europe External Pacemaker Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 52 Asia Pacific External Pacemaker Market Outlook, By Country (2023-2034) ($MN)
  • Table 53 Asia Pacific External Pacemaker Market Outlook, By Device (2023-2034) ($MN)
  • Table 54 Asia Pacific External Pacemaker Market Outlook, By Single Chamber (2023-2034) ($MN)
  • Table 55 Asia Pacific External Pacemaker Market Outlook, By Dual Chamber (2023-2034) ($MN)
  • Table 56 Asia Pacific External Pacemaker Market Outlook, By Application (2023-2034) ($MN)
  • Table 57 Asia Pacific External Pacemaker Market Outlook, By Acute Myocardial Infarction (2023-2034) ($MN)
  • Table 58 Asia Pacific External Pacemaker Market Outlook, By Bradycardia (2023-2034) ($MN)
  • Table 59 Asia Pacific External Pacemaker Market Outlook, By Heart Block (2023-2034) ($MN)
  • Table 60 Asia Pacific External Pacemaker Market Outlook, By Post-Operative Care (2023-2034) ($MN)
  • Table 61 Asia Pacific External Pacemaker Market Outlook, By Tachycardia (2023-2034) ($MN)
  • Table 62 Asia Pacific External Pacemaker Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 63 Asia Pacific External Pacemaker Market Outlook, By End User (2023-2034) ($MN)
  • Table 64 Asia Pacific External Pacemaker Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 65 Asia Pacific External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 66 Asia Pacific External Pacemaker Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 67 Asia Pacific External Pacemaker Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 68 Asia Pacific External Pacemaker Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 69 South America External Pacemaker Market Outlook, By Country (2023-2034) ($MN)
  • Table 70 South America External Pacemaker Market Outlook, By Device (2023-2034) ($MN)
  • Table 71 South America External Pacemaker Market Outlook, By Single Chamber (2023-2034) ($MN)
  • Table 72 South America External Pacemaker Market Outlook, By Dual Chamber (2023-2034) ($MN)
  • Table 73 South America External Pacemaker Market Outlook, By Application (2023-2034) ($MN)
  • Table 74 South America External Pacemaker Market Outlook, By Acute Myocardial Infarction (2023-2034) ($MN)
  • Table 75 South America External Pacemaker Market Outlook, By Bradycardia (2023-2034) ($MN)
  • Table 76 South America External Pacemaker Market Outlook, By Heart Block (2023-2034) ($MN)
  • Table 77 South America External Pacemaker Market Outlook, By Post-Operative Care (2023-2034) ($MN)
  • Table 78 South America External Pacemaker Market Outlook, By Tachycardia (2023-2034) ($MN)
  • Table 79 South America External Pacemaker Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 80 South America External Pacemaker Market Outlook, By End User (2023-2034) ($MN)
  • Table 81 South America External Pacemaker Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 82 South America External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 83 South America External Pacemaker Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 84 South America External Pacemaker Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 85 South America External Pacemaker Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 86 Middle East & Africa External Pacemaker Market Outlook, By Country (2023-2034) ($MN)
  • Table 87 Middle East & Africa External Pacemaker Market Outlook, By Device (2023-2034) ($MN)
  • Table 88 Middle East & Africa External Pacemaker Market Outlook, By Single Chamber (2023-2034) ($MN)
  • Table 89 Middle East & Africa External Pacemaker Market Outlook, By Dual Chamber (2023-2034) ($MN)
  • Table 90 Middle East & Africa External Pacemaker Market Outlook, By Application (2023-2034) ($MN)
  • Table 91 Middle East & Africa External Pacemaker Market Outlook, By Acute Myocardial Infarction (2023-2034) ($MN)
  • Table 92 Middle East & Africa External Pacemaker Market Outlook, By Bradycardia (2023-2034) ($MN)
  • Table 93 Middle East & Africa External Pacemaker Market Outlook, By Heart Block (2023-2034) ($MN)
  • Table 94 Middle East & Africa External Pacemaker Market Outlook, By Post-Operative Care (2023-2034) ($MN)
  • Table 95 Middle East & Africa External Pacemaker Market Outlook, By Tachycardia (2023-2034) ($MN)
  • Table 96 Middle East & Africa External Pacemaker Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 97 Middle East & Africa External Pacemaker Market Outlook, By End User (2023-2034) ($MN)
  • Table 98 Middle East & Africa External Pacemaker Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 99 Middle East & Africa External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 100 Middle East & Africa External Pacemaker Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 101 Middle East & Africa External Pacemaker Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 102 Middle East & Africa External Pacemaker Market Outlook, By Other End Users (2023-2034) ($MN)